Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
BNRE20220008BUndetermined Publication Date: 2023-01-31AMGEN INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- BNRE20220008
- Authority / Receiving Office
- BN · BN
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2011-03-14
- Filing Date
- 2022-12-15
- Publication Date
- 2023-01-31
- Estimated Expiration
- 2042-12-15
Need to check novelty before this filing date? Find Prior Art
No text content released.